secwatch.observer — SEC 8-K summary
======================================

Issuer:     bluebird bio, Inc. (—)
CIK:        0001293971
Form:       8-K
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0001293971-24-000090
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

bluebird bio effects 1-for-20 reverse stock split; shares trade split-adjusted Dec 13
--------------------------------------------------------------------------------

- Effective Dec 12, 2024 at 5:00 p.m. ET; new CUSIP 09609G 209.
- Every 20 pre-split shares convert to 1 share; no fractional shares issued.
- Authorized shares and par value unchanged; trading symbol remains BLUE.
- Split approved by stockholders Dec 4, 2024; board chose 1-for-20 ratio.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1293971/000129397124000090/0001293971-24-000090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1293971/000129397124000090/blue-20241212.htm
  HTML page:      https://secwatch.observer/filing/0001293971-24-000090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer